Literature DB >> 25387097

Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.

B Dhakal1, A Singavi2, E P Cohen3, M Dangal3, J Palmer1, A Dall3, A D'Souza1, M Hamadani1, P N Hari1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25387097     DOI： 10.1038/bmt.2014.261

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Preferential activation of Th2 cells in chronic graft-versus-host reaction.

Authors:  D De Wit; M Van Mechelen; C Zanin; J M Doutrelepont; T Velu; C Gérard; D Abramowicz; J P Scheerlinck; P De Baetselier; J Urbain
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

2.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

Review 3.  [Membranous nephropathy with nephrotic syndrome developed after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia].

Authors:  Mizuki Aimoto; Takahisa Yamane; Mitsuru Ichii; Katsuhito Mori; Ran Moriguchi-Aimoto; Eri Wada-Inoue; Hideo Koh; Takahiko Nakane; Yasunobu Takeoka; Mika Akahori-Nakamae; Saori Nishiki-Kosaka; Yoshiki Terada; Hirohisa Nakamae; Ki-Ryang Koh; Takafumi Nakao; Masahiko Ohsawa; Kenichi Wakasa; Eiji Ishimura; Masaaki Inaba; Masayuki Hino
Journal:  Rinsho Ketsueki       Date:  2011-07

Review 4.  The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature

Authors:  Pasquale Niscola; Andrea Tendas; Xiao-dan Luo; Gianfranco Catalano; Laura Scaramucci; Luca Cupelli; Marco Giovannini; Michele Ferrannini; Francesco Bondanini; Daniela Piccioni; Teresa Dentamaro; Roberto Palumbo; Alessio Pio Perrotti; Qi-fa Liu; Paolo de Fabritiis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2013-03

Review 5.  Chronic graft-versus-host disease: clinical manifestation and therapy.

Authors:  V Ratanatharathorn; L Ayash; H M Lazarus; J Fu; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2001-07       Impact factor: 5.483

6.  Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis.

Authors:  Xiao-dan Luo; Qi-fa Liu; Yu Zhang; Jing Sun; Guo-bao Wang; Zhi-ping Fan; Zheng-shan Yi; Yi-wen Ling; Yong-qiang Wei; Xiao-li Liu; Bing Xu
Journal:  Blood Cells Mol Dis       Date:  2011-01-05       Impact factor: 3.039

7.  Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  P Reddy; K Johnson; J P Uberti; C Reynolds; S Silver; L Ayash; T M Braun; V Ratanatharathorn
Journal:  Bone Marrow Transplant       Date:  2006-07-24       Impact factor: 5.483

8.  Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

Authors:  Voravit Ratanatharathorn; Lois Ayash; Christopher Reynolds; Samuel Silver; Pavan Reddy; Michael Becker; James L M Ferrara; Joseph P Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2003-08       Impact factor: 5.742

9.  Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.

Authors:  Pilar Fraile; Fraile Pilar; Lourdes Vazquez; Vazquez Lourdes; Dolores Caballero; Caballero Dolores; Pedro Garcia-Cosmes; Garcia-Cosmes Pedro; Lucia López; López Lucia; Jesus San Miguel; San Miguel Jesus; Jose Matias Tabernero; Tabernero Jose Matias
Journal:  Eur J Haematol       Date:  2013-06-28       Impact factor: 2.997

Review 10.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829
View more
  2 in total

1.  Very late-onset reversible cardiomyopathy in patients with chronic GvHD.

Authors:  H Kawano; H Tanaka; T Yamashita; K-I Hirata; S Ishii; T Suzuki; K Wakahashi; Y Kawano; A Sada; K Minagawa; F Kawakami; T Itoh; A Baba; T Matsui; Y Katayama
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

2.  Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome.

Authors:  Omar Elghawy; John S Wang; Alexander C Hafey; Amanda D Renaghan; Rachel M Whitehair; Tamila L Kindwall-Keller
Journal:  Case Rep Nephrol Dial       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.